and post-polycythemia vera myelofibrosis

Selinexor Receives Fast Track Designation from FDA for Myelofibrosis Treatment

Source – Karyopharm Therapeutics The FDA has granted fast track designation to selinexor (Xpovio) for the treatment of patients with ...